世界の抗生物質医薬品市場（2024年版）：薬剤クラス別（セファロスポリン、ペニシリン、マクロライド、フルオロキノロン、その他）、スペクトラム別（ブロード、ナロー）、適応症別、地域別、国別の分析：市場の洞察と予測（2019-2029年）

Global Antibiotic Drugs Market (2024 Edition): Analysis By Drug Class (Cephalosporin, Penicillin, Macrolides, Fluoroquinolone, Others), Spectrum (Broad, Narrow), By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)

エグゼクティブ・サマリーこの調査レポートは世界の抗生物質医薬品産業を薬剤クラス別（セファロスポリン、ペニシリン、マクロライド、フルオロキノロン、その他）、スペクトラム別、適応症別（肺炎、髄膜炎... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Azoth Analytics アーゾスアナリティクス	2024年2月1日	US$2,450 シングルユーザライセンスライセンス・価格情報注文方法はこちら	260	英語

サマリー

エグゼクティブ・サマリー

この調査レポートは世界の抗生物質医薬品産業を薬剤クラス別（セファロスポリン、ペニシリン、マクロライド、フルオロキノロン、その他）、スペクトラム別、適応症別（肺炎、髄膜炎、消化器感染症、尿路感染症、その他の適応症）に細分化して分析しています、2019-2022年の過去期間、2023年の推定期間、2024-2029年の予測期間について、薬剤クラス別（セファロスポリン、ペニシリン、マクロライド、フルオロキノン、その他）、スペクトラム別（ブロード、ナロー）、適応症別（肺炎、髄膜炎、消化器感染症、尿路感染症、その他の適応症）、地域別、国別の分析を掲載しています。

この調査レポートは、地域（米州、欧州、APAC、中東アフリカ）と10カ国（米国、カナダ、ドイツ、英国、フランス、イタリア、スペイン、中国、日本、インド）の詳細な分析をカバーしています。さらに、市場規模、年間成長＆潜在力分析、市場プレイヤーの競合調査、投資機会、需要予測などのデータも提示しています。

また、市場成長指標、阻害要因、需給リスク、その他の重要統計、市場の進化に関連する現在および将来の市場動向の完全評価も行っています。予測期間2024-2029年、世界の抗生物質医薬品市場は年平均成長率4.7%で成長すると予測される

世界の抗生物質医薬品市場は、2022年の504億1,000万米ドルから2029年末までに739億2,000万米ドルを創出する見込みです。抗生物質医薬品市場は、長年にわたり着実な成長を遂げている。細菌感染症の増加、抗生物質耐性の永続的な進化が、革新的な抗生物質療法の需要を後押ししている。同市場は、セファロスポリン系、フルオロキノロン系、マクロライド系、テトラサイクリン系など多様な抗生物質によって特徴付けられ、それぞれが細菌感染症への対処において明確な役割を果たしている。

迅速かつ効率的な抗生物質治療の重要性が医療界や一般市民の間で認識されるようになり、需要が増加している。責任ある抗生物質の使用を提唱し、抗生物質耐性の影響に関する教育を提供するプログラムは、市場動向に影響を与える重要な役割を果たしている。抗生物質耐性の脅威の高まりは、新しい抗生物質を開発し、既存の抗生物質の有効性を維持するための世界的な努力を促している。製薬会社、研究機関、政府機関の共同イニシアティブは、この重大な医療課題に対処することを目的としている。

レポートの範囲

- 本レポートは、抗生物質医薬品市場を金額（10億米ドル）別に分析しています。

- 2019-2022年の過去期間、2023年の推定期間、2024-2029年の予測期間における抗生物質医薬品市場の分析を掲載しています。

- 抗生物質医薬品市場を薬剤クラス別（セファロスポリン、ペニシリン、マクロライド、フルオロキノロン、その他の薬剤クラス）に分析しています。

- 抗生物質医薬品市場をスペクトラム別（広域スペクトラム、狭域スペクトラム）に分析しています。

- 抗生物質医薬品市場を適応症別（肺炎、髄膜炎、消化器感染症、尿路感染症、その他の適応症）に分析しています。

- 本レポートの主要な洞察は、SWOTおよびポーターのファイブフォース分析の枠組みを通して提示されています。また、市場の魅力を地域別、薬剤クラス別、スペクトラム別、適応症別に紹介しています。

- また、業界の主な機会、動向、促進要因、課題についても分析しています。

- 競合の動向、戦略、M&A、新製品開発についても追跡しています。本レポートで分析している企業は、アボット・ラボラトリーズ、ジョンソン・エンド・ジョンソン、ファイザー、GSK PLC、ノバルティスAG、ロシュ・ホールディングAG、バイエルAG、メルク・アンド・カンパニー、ヴィアトリス・インク、シプラなどです。

ページTOPに戻る

1. Market Background

1.1 Scope and Product Outlook

1.2 Executive Summary

1.3 Research Methodology

2. Strategic Recommendations

3. Global Antibiotic Drugs Market: Historic and Forecast (2019-2029)

3.1 Global Prevalence of Infectious Diseases, 2019

3.2 Global Incidence of Infectious Diseases, 2019

3.3 Top 10 most prescribed outpatient antibiotics

3.4 Global Antibiotic Drugs Market: Dashboard

3.5 Global Antibiotic Drugs Market: Market Value Assessment, 2019-2029 (USD Billion)

3.6 Impact of COVID-19 on Global Antibiotic Drugs Market

3.7 Global Antibiotic Drugs Market Segmentation: By Drug Class

3.7.1 Global Antibiotic Drugs Market, By Drug Class Overview

3.7.2 Global Antibiotic Drugs Market Size, By Cephalosporin, By Value, 2019H-2029F (USD Billion & CAGR)

3.7.3 Global Antibiotic Drugs Market Size, By Penicillin, By Value, 2019H-2029F (USD Billion & CAGR)

3.7.4 Global Antibiotic Drugs Market Size, By Macrolides, By Value, 2019H-2029F (USD Billion & CAGR)

3.7.5 Global Antibiotic Drugs Market Size, By Fluoroquinolone, By Value, 2019H-2029F (USD Billion & CAGR)

3.7.6 Global Antibiotic Drugs Market Size, By Other Drug Classes, By Value, 2019H-2029F (USD Billion & CAGR)

3.8 Global Antibiotic Drugs Market Segmentation: By Spectrum

3.8.1 Global Antibiotic Drugs Market, By Spectrum Overview

3.8.2 Global Antibiotic Drugs Market Size, By Broad Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)

3.8.3 Global Antibiotic Drugs Market Size, By Narrow Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)

3.9 Global Antibiotic Drugs Market Segmentation: By Indication

3.9.1 Global Antibiotic Drugs Market, By Indication Overview

3.9.2 Global Antibiotic Drugs Market Size, By Pneumonia By Value, 2019H-2029F (USD Billion & CAGR)

3.9.3 Global Antibiotic Drugs Market Size, By Meningitis, By Value, 2019H-2029F (USD Billion & CAGR)

3.9.4 Global Antibiotic Drugs Market Size, By Gastrointestinal infections, By Value, 2019H-2029F (USD Billion & CAGR)

3.9.5 Global Antibiotic Drugs Market Size, By Urinary Tract Infections, By Value, 2019H-2029F (USD Billion & CAGR)

3.9.6 Global Antibiotic Drugs Market Size, By Other Indications, By Value, 2019H-2029F (USD Billion & CAGR)

4. Global Antibiotic Drugs Market, Region Analysis

4.1 Regional Coverage of the Study

4.2 Regional Snapshot

5. Americas Antibiotic Drugs Market: Historic and Forecast (2019-2029)

5.1 Americas Antibiotic Drugs Market: Snapshot

5.2 Americas Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

5.3 Americas Antibiotic Drugs Market: Key Factors

5.4 Americas Antibiotic Drugs Market: Segment Analysis

5.5 Americas Antibiotic Drugs Market Segmentation: By Drug Class

5.5.1 Americas Antibiotic Drugs Market, By Drug Class Overview

5.5.2 Americas Antibiotic Drugs Market Size, By Cephalosporin, By Value, 2019H-2029F (USD Billion & CAGR)

5.5.3 Americas Antibiotic Drugs Market Size, By Penicillin, By Value, 2019H-2029F (USD Billion & CAGR)

5.5.4 Americas Antibiotic Drugs Market Size, By Macrolides, By Value, 2019H-2029F (USD Billion & CAGR)

5.5.5 Americas Antibiotic Drugs Market Size, By Fluoroquinolone, By Value, 2019H-2029F (USD Billion & CAGR)

5.5.6 Americas Antibiotic Drugs Market Size, By Other Drug Classes, By Value, 2019H-2029F (USD Billion & CAGR)

5.6 Americas Antibiotic Drugs Market Segmentation: By Spectrum

5.6.1 Americas Antibiotic Drugs Market, By Spectrum Overview

5.6.2 Americas Antibiotic Drugs Market Size, By Broad Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)

5.6.3 Americas Antibiotic Drugs Market Size, By Narrow spectrum, By Value, 2019H-2029F (USD Billion & CAGR)

5.7 Americas Antibiotic Drugs Market Segmentation: By Indication

5.7.1 Americas Antibiotic Drugs Market, By Indication Overview

5.7.2 Americas Antibiotic Drugs Market Size, By Pneumonia, By Value, 2019H-2029F (USD Billion & CAGR)

5.7.3 Americas Antibiotic Drugs Market Size, By Meningitis, By Value, 2019H-2029F (USD Billion & CAGR)

5.7.4 Americas Antibiotic Drugs Market Size, By Gastrointestinal infections, By Value, 2019H-2029F (USD Billion & CAGR)

5.7.5 Americas Antibiotic Drugs Market Size, By Urinary Tract Infections, By Value, 2019H-2029F (USD Billion & CAGR)

5.7.6 Americas Antibiotic Drugs Market Size, By Other Indications, By Value, 2019H-2029F (USD Billion & CAGR)

5.8 Americas Antibiotic Drugs Market Segmentation: By Country

5.8.1 United States Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

5.8.1.1 United States Antibiotic Drugs Market, By Drug Class

5.8.1.2 United States Antibiotic Drugs Market, By Spectrum

5.8.1.3 United States Antibiotic Drugs Market, By Indication

5.8.2 Canada Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

5.8.2.1 Canada Antibiotic Drugs Market, By Drug Class

5.8.2.2 Canada Antibiotic Drugs Market, By Spectrum

5.8.2.3 Canada Antibiotic Drugs Market, By Indication

5.8.3 Rest of Americas Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

5.8.3.1 Rest of Americas Antibiotic Drugs Market, By Drug Class

5.8.3.2 Rest of Americas Antibiotic Drugs Market, By Spectrum

5.8.3.3 Rest of Americas Antibiotic Drugs Market, By Indication

6. Europe Antibiotic Drugs Market: Historic and Forecast (2019-2029)

6.1 Europe Antibiotic Drugs Market: Snapshot

6.2 Europe Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.3 Europe Antibiotic Drugs Market: Key Factors

6.4 Europe Antibiotic Drugs Market: Segment Analysis

6.5 Europe Antibiotic Drugs Market Segmentation: By Drug Class

6.5.1 Europe Antibiotic Drugs Market, By Drug Class Overview

6.5.2 Europe Antibiotic Drugs Market Size, By Cephalosporin, By Value, 2019H-2029F (USD Billion & CAGR)

6.5.3 Europe Antibiotic Drugs Market Size, By Penicillin, By Value, 2019H-2029F (USD Billion & CAGR)

6.5.4 Europe Antibiotic Drugs Market Size, By Macrolides, By Value, 2019H-2029F (USD Billion & CAGR)

6.5.5 Europe Antibiotic Drugs Market Size, By Fluoroquinolone, By Value, 2019H-2029F (USD Billion & CAGR)

6.5.6 Europe Antibiotic Drugs Market Size, By Other Drug Classes, By Value, 2019H-2029F (USD Billion & CAGR)

6.6 Europe Antibiotic Drugs Market Segmentation: By Spectrum

6.6.1 Europe Antibiotic Drugs Market, By Spectrum Overview

6.6.2 Europe Antibiotic Drugs Market Size, By Broad Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)

6.6.3 Europe Antibiotic Drugs Market Size, By Narrow Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)

6.7 Europe Antibiotic Drugs Market Segmentation: By Indication

6.7.1 Europe Antibiotic Drugs Market, By Indication Overview

6.7.2 Europe Antibiotic Drugs Market Size, By Pneumonia, By Value, 2019H-2029F (USD Billion & CAGR)

6.7.3 Europe Antibiotic Drugs Market Size, By Meningitis, By Value, 2019H-2029F (USD Billion & CAGR)

6.7.4 Europe Antibiotic Drugs Market Size, By Gastrointestinal infections, By Value, 2019H-2029F (USD Billion & CAGR)

6.7.5 Europe Antibiotic Drugs Market Size, By Urinary Tract Infections, By Value, 2019H-2029F (USD Billion & CAGR)

6.7.6 Europe Antibiotic Drugs Market Size, By Other Indications, By Value, 2019H-2029F (USD Billion & CAGR)

6.8 Europe Antibiotic Drugs Market Segmentation: By Country

6.8.1 Germany Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.8.1.1 Germany Antibiotic Drugs Market, By Drug Class

6.8.1.2 Germany Antibiotic Drugs Market, By Spectrum

6.8.1.3 Germany Antibiotic Drugs Market, By Indication

6.8.2 United Kingdom Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.8.2.1 United Kingdom Antibiotic Drugs Market, By Drug Class

6.8.2.2 United Kingdom Antibiotic Drugs Market, By Spectrum

6.8.2.3 United Kingdom Antibiotic Drugs Market, By Indication

6.8.3 France Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.8.3.1 France Antibiotic Drugs Market, By Drug Class

6.8.3.2 France Antibiotic Drugs Market, By Spectrum

6.8.3.3 France Antibiotic Drugs Market, By Indication

6.8.4 Italy Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.8.4.1 Italy Antibiotic Drugs Market, By Drug Class

6.8.4.2 Italy Antibiotic Drugs Market, By Spectrum

6.8.4.3 Italy Antibiotic Drugs Market, By Indication

6.8.5 Spain Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.8.5.1 Spain Antibiotic Drugs Market, By Drug Class

6.8.5.2 Spain Antibiotic Drugs Market, By Spectrum

6.8.5.3 Spain Antibiotic Drugs Market, By Indication

6.8.6 Rest of Europe Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.8.6.1 Rest of Europe Antibiotic Drugs Market, By Drug Class

6.8.6.2 Rest of Europe Antibiotic Drugs Market, By Spectrum

6.8.6.3 Rest of Europe Antibiotic Drugs Market, By Indication

7. Asia-Pacific Antibiotic Drugs Market: Historic and Forecast (2019-2029)

7.1 Asia-Pacific Antibiotic Drugs Market: Snapshot

7.2 Asia-Pacific Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

7.3 Asia-Pacific Antibiotic Drugs Market: Key Factors

7.4 Asia-Pacific Antibiotic Drugs Market: Segment Analysis

7.5 Asia-Pacific Antibiotic Drugs Market Segmentation: By Drug Class

7.5.1 Asia-Pacific Antibiotic Drugs Market, By Drug Class Overview

7.5.2 Asia-Pacific Antibiotic Drugs Market Size, By Cephalosporin, By Value, 2019H-2029F (USD Billion & CAGR)

7.5.3 Asia-Pacific Antibiotic Drugs Market Size, By Penicillin, By Value, 2019H-2029F (USD Billion & CAGR)

7.5.4 Asia-Pacific Antibiotic Drugs Market Size, By Macrolides, By Value, 2019H-2029F (USD Billion & CAGR)

7.5.5 Asia-Pacific Antibiotic Drugs Market Size, By Fluoroquinolone, By Value, 2019H-2029F (USD Billion & CAGR)

7.5.6 Asia-Pacific Antibiotic Drugs Market Size, By Other Drug Classes, By Value, 2019H-2029F (USD Billion & CAGR)

7.6 Asia-Pacific Antibiotic Drugs Market Segmentation: By Spectrum

7.6.1 Asia-Pacific Antibiotic Drugs Market, By Spectrum Overview

7.6.2 Asia-Pacific Antibiotic Drugs Market Size, By Broad Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)

7.6.3 Asia-Pacific Antibiotic Drugs Market Size, By Narrow Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)

7.7 Asia-Pacific Antibiotic Drugs Market Segmentation: By Indication

7.7.1 Asia-Pacific Antibiotic Drugs Market, By Indication Overview

7.7.2 Asia-Pacific Antibiotic Drugs Market Size, By Pneumonia, By Value, 2019H-2029F (USD Billion & CAGR)

7.7.3 Asia-Pacific Antibiotic Drugs Market Size, By Meningitis, By Value, 2019H-2029F (USD Billion & CAGR)

7.7.4 Asia-Pacific Antibiotic Drugs Market Size, By Gastrointestinal infections, By Value, 2019H-2029F (USD Billion & CAGR)

7.7.5 Asia-Pacific Antibiotic Drugs Market Size, By Urinary Tract Infections, By Value, 2019H-2029F (USD Billion & CAGR)

7.7.6 Asia-Pacific Antibiotic Drugs Market Size, By Other Indications, By Value, 2019H-2029F (USD Billion & CAGR)

7.8 Asia-Pacific Antibiotic Drugs Market Segmentation: By Country

7.8.1 China Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

7.8.1.1 China Antibiotic Drugs Market, By Drug Class

7.8.1.2 China Antibiotic Drugs Market, By Spectrum

7.8.1.3 China Antibiotic Drugs Market, By Indication

7.8.2 Japan Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

7.8.2.1 Japan Antibiotic Drugs Market, By Drug Class

7.8.2.2 Japan Antibiotic Drugs Market, By Spectrum

7.8.2.3 Japan Antibiotic Drugs Market, By Indication

7.8.2 India Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

7.8.2.1 India Antibiotic Drugs Market, By Drug Class

7.8.2.2 India Antibiotic Drugs Market, By Spectrum

7.8.2.3 India Antibiotic Drugs Market, By Indication

7.8.3 Rest of Asia-Pacific Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

7.8.3.1 Rest of Asia-Pacific Antibiotic Drugs Market, By Drug Class

7.8.3.2 Rest of Asia-Pacific Antibiotic Drugs Market, By Spectrum

7.8.3.3 Rest of Asia-Pacific Antibiotic Drugs Market, By Indication

8. Middle-East & Africa Antibiotic Drugs Market: Historic and Forecast (2019-2029)

8.1 Middle-East & Africa Antibiotic Drugs Market: Snapshot

8.2 Middle-East & Africa Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

8.3 Middle-East & Africa Antibiotic Drugs Market: Key Factors

8.4 Middle-East & Africa Antibiotic Drugs Market: Segment Analysis

8.5 Middle-East & Africa Antibiotic Drugs Market Segmentation: By Drug Class

8.5.1 Middle-East & Africa Antibiotic Drugs Market, By Drug Class Overview

8.5.2 Middle-East & Africa Antibiotic Drugs Market Size, By Cephalosporin, By Value, 2019H-2029F (USD Billion & CAGR)

8.5.3 Middle-East & Africa Antibiotic Drugs Market Size, By Penicillin, By Value, 2019H-2029F (USD Billion & CAGR)

8.5.4 Middle-East & Africa Antibiotic Drugs Market Size, By Macrolides, By Value, 2019H-2029F (USD Billion & CAGR)

8.5.5 Middle-East & Africa Antibiotic Drugs Market Size, By Fluoroquinolone, By Value, 2019H-2029F (USD Billion & CAGR)

8.5.6 Middle-East & Africa Antibiotic Drugs Market Size, By Other Drug Classes, By Value, 2019H-2029F (USD Billion & CAGR)

8.6 Middle-East & Africa Antibiotic Drugs Market Segmentation: By Spectrum

8.6.1 Middle-East & Africa Antibiotic Drugs Market, By Spectrum Overview

8.6.2 Middle-East & Africa Antibiotic Drugs Market Size, By Broad Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)

8.6.3 Middle-East & Africa Antibiotic Drugs Market Size, By Narrow Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)

8.7 Middle-East & Africa Antibiotic Drugs Market Segmentation: By Indication

8.7.1 Middle-East & Africa Antibiotic Drugs Market, By Indication: Overview

8.7.2 Middle-East & Africa Antibiotic Drugs Market Size, By Pneumonia, By Value, 2019H-2029F (USD Billion & CAGR)

8.7.3 Middle-East & Africa Antibiotic Drugs Market Size, By Meningitis, By Value, 2019H-2029F (USD Billion & CAGR)

8.7.4 Middle-East & Africa Antibiotic Drugs Market Size, By Gastrointestinal infections, By Value, 2019H-2029F (USD Billion & CAGR)

8.7.5 Middle-East & Africa Antibiotic Drugs Market Size, By Urinary Tract Infections, By Value, 2019H-2029F (USD Billion & CAGR)

8.7.6 Middle-East & Africa Antibiotic Drugs Market Size, By Other Indications, By Value, 2019H-2029F (USD Billion & CAGR)

9. Market Dynamics

9.1 Impact Assessment of Market Dynamics on the Global Antibiotic Drugs Market

9.2 Drivers

9.3 Restraints

9.4 Trends

10. Porter’s Five Forces Analysis

10.1 Porter’s Five Forces Model

11. Competitive Positioning

11.1 Companies’ Product Positioning

11.2 Market Position Matrix

11.3 Market Share Analysis of Antibiotic Drugs Market

11.4 Company Profiles

11.4.1 Abbott Laboratories

11.4.2 Johnson & Johnson

11.4.3 Pfizer

11.4.4 GSK PLC

11.4.5 Novartis AG

11.4.6 Roche Holding AG

11.4.7 Bayer AG

11.4.8 Merck & Co., Inc.

11.4.9 Viatris Inc.

11.4.10 Cipla

ページTOPに戻る

Table of Contents

Summary

Executive Summary

Azoth Analytics has released a research report titled “Global Antibiotic Drugs Market (2024 Edition)” which provides a complete analysis of the global Antibiotic Drugs industry in terms of market segmentation By Drug Class (Cephalosporin, Penicillin, Macrolides, Fluoroquinolone, Others), Spectrum (Broad, Narrow), By Indication (Pneumonia, Meningitis, Gastrointestinal infections, Urinary Tract Infections, Other Indications), By Region and By Country for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.

The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast.

The research study also assesses market growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market's evolution. During the forecast period, 2024-2029, the Global Antibiotic Drugs market is expected to grow at a CAGR of 4.7%

The Global Antibiotic Drugs Market is expected to generate USD 73.92 Billion by the end of 2029, up from USD 50.41 Billion in 2022. The antibiotic drugs market has witnessed steady growth over the years. The increasing prevalence of bacterial infections, coupled with the perpetual evolution of antibiotic resistance, propels the demand for innovative antibiotic therapies. The market is characterized by a diverse range of antibiotics, including Cephalosporins, fluoroquinolones, macrolides, and tetracyclines, each playing a distinct role in addressing bacterial infections.

The increased recognition of the significance of prompt and efficient antibiotic treatment within the healthcare community and the general populace catalyse increased demand. Programs advocating for responsible antibiotic usage and providing education about the repercussions of antibiotic resistance play a crucial role in influencing market trends. The escalating threat of antibiotic resistance has prompted concerted global efforts to develop new antibiotics and preserve the effectiveness of existing ones. Collaborative initiatives between pharmaceutical companies, research institutions, and governmental bodies aim to address this critical healthcare challenge.

Scope of the Report

• The report analyses the Antibiotic Drugs Market by Value (USD Billion).

• The report presents the analysis of the Antibiotic Drugs Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.

• The report analyses the Antibiotic Drugs Market by Drug Class (Cephalosporin, Penicillin, Macrolides, Fluoroquinolone, Other Drug Classes).

• The report analyses the Antibiotic Drugs Market By Spectrum (Broad Spectrum, Narrow Spectrum)

• The report analyses the Antibiotic Drugs Market By Indication (Pneumonia, Meningitis, Gastrointestinal infections, Urinary Tract Infections, Other Indications).

• The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by Drug Class, By Spectrum & By Indication.

• Also, the major opportunities, trends, drivers, and challenges of the industry have been analyzed in the report.

• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Abbott Laboratories, Johnson & Johnson, Pfizer, GSK PLC, Novartis AG, Roche Holding AG, Bayer AG, Merck & Co., Inc., Viatris Inc. and Cipla.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

Azoth Analytics社の医療・製薬分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

Azoth Analytics社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療）の最新刊レポート

Azoth Analytics社の医療・製薬分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

Azoth Analytics社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?